Protea Fund-Sectoral Biotech Opportunities Fund IF USD

Reference Data

ISIN LU1176839154
Valor Number 26967217
Bloomberg Global ID
Fund Name Protea Fund-Sectoral Biotech Opportunities Fund IF USD
Fund Provider Sectoral Asset Management Inc 1010 Sherbrooke St. West, Suite 1610
QC H3A 2R7 Montreal
Canada
Phone: +1 514 849 8777
E-Mail: BusinessDevelopment@sectoral.com
Fund Provider Sectoral Asset Management Inc
Representative in Switzerland FundPartner Solutions (Suisse) SA
Genève 75
Distributor(s)
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel)
Redemption Condition The fund management company and/or distributor charges a redemption commission (different commissions can be charged for the same fund depending on the sales channel)
Investment Strategy *** This Sub-Fund aims to achieve capital growth in USD. While respecting the principle of risk diversification, the Sub-Fund’s assets are primarily invested in equities, equity-like transferable securities, participation certificates etc. issued by particularly innovative small, mid and large cap biotech companies worldwide which are active in the human medicine sector and depositary receipts, such as American Depositary Receipts (ADRs), Global Depositary Receipts (GDRs) and European Depositary Receipts (EDRs), referring to such securities. While no geographical restrictions apply re. specific countries or regions, the industry and therefore the Sub-Fund’s investments are centered in North America and Western Europe.
Peculiarities

Fund Prices

Current Price * 9.11 USD 25.06.2025
Previous Price * 9.16 USD 24.06.2025
52 Week High * 10.39 USD 13.09.2024
52 Week Low * 7.84 USD 08.04.2025
NAV * 9.11 USD 25.06.2025
Issue Price * 9.11 USD 25.06.2025
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 21,774,581
Unit/Share Assets *** 16,138,887
Trading Information SIX

Performance

YTD Performance +0.11% 31.12.2024
25.06.2025
YTD Performance (in CHF) -11.22% 31.12.2024
25.06.2025
1 month +4.23% 27.05.2025
25.06.2025
3 months -1.94% 25.03.2025
25.06.2025
6 months -0.76% 27.12.2024
25.06.2025
1 year -7.23% 25.06.2024
25.06.2025
2 years -0.87% 26.06.2023
25.06.2025
3 years +5.68% 27.06.2022
25.06.2025
5 years -9.44% 25.06.2020
25.06.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Amgen Inc 8.27%
Vertex Pharmaceuticals Inc 8.18%
Gilead Sciences Inc 7.75%
AstraZeneca PLC ADR 4.90%
Regeneron Pharmaceuticals Inc 4.87%
argenx SE ADR 3.95%
Alnylam Pharmaceuticals Inc 3.59%
Insmed Inc 2.66%
BeOne Medicines Ltd ADR 2.58%
Blueprint Medicines Corp 2.55%
Last data update 31.05.2025

Cost / Risk

TER 1.39%
TER date 30.06.2023
Performance Fee ***
PTR
Max. Management Fee *** 1.10%
Ongoing Charges *** 1.80%
SRRI ***
SRRI date *** 31.05.2025

Breakdowns

Equity Countries ***

Equity Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)